Dyax/Bayer Schering Ink Antibody Discovery Agreement

External licensing and discovery agreements support internal pipeline growth, goal of total integration, Dyax CEO tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet